This report focuses on the results of compliance verification and enforcement activities in 2017 for licensees in the medical, industrial, academic and research, commercial, and waste nuclear substances sectors.
Failure to comply with regulatory requirements for management oversight of the radiation protection program, and for worker training, prescribed records, ascertainment of doses and transportation of nuclear gauges
Am I safe? This short question is often difficult to answer for public communicators during a nuclear or radiological emergency.
The report details expert-level discussions that were held on addressing this and other communication challenges.
Participant funding is currently available for the November 6-7, 2019 meeting to assist Indigenous peoples, members of the public, and stakeholders in reviewing the Regulatory Oversight Report for Canadian Nuclear Power Generating Sites: 2018 and the Regulatory Oversight Report on the Use of Nuclear Substances in Canada: 2018, and submitting comments to the Commission.
The CNSC received no feedback on comments for REGDOC-3.1.3, Reporting Requirements for Waste Nuclear Substance Licensees, Class II Nuclear Facilities and Users of Prescribed Equipment, Nuclear Substances and Radiation Devices.
Licensee must cease all use of its portable devices until it can demonstrate an effective management oversight of its radiation protection program and that all previous non-compliances have been corrected.
Participant funding is currently available for Canadian Nuclear Laboratories Ltd.’s Near Surface Disposal Facility project, the In Situ decommissioning of the Whiteshell Reactor-1 project and the Nuclear Power Demonstration Closure project.
Participant funding is currently available for the October 2–3, 2019 meeting to assist Indigenous peoples, members of the public, and stakeholders in reviewing the Regulatory Oversight Report for Canadian Nuclear Laboratories Sites: 2018 and submitting comments to the Commission.
Participant funding is currently available for the October 2–3, 2019 hearing to consider the licence renewal for nuclear research and test establishment decommissioning licence for the Whiteshell Laboratories site